方盛制药(603998.SH)：第三季净利润9904.46万元，同比增长8.49%

Core Viewpoint - Fangsheng Pharmaceutical (603998.SH) reported a decline in revenue for the third quarter, while net profit showed an increase, indicating mixed financial performance [1] Financial Performance - The company achieved operating revenue of 419 million yuan in the third quarter, a year-on-year decrease of 4.26% [1] - Net profit attributable to shareholders was 99.04 million yuan, reflecting a year-on-year increase of 8.49% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 71.20 million yuan, representing a year-on-year growth of 36.37% [1] - Basic earnings per share were reported at 0.22 yuan [1]